Skip to search formSkip to main contentSkip to account menu

Ircinia oros

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Scolex morphology of monozoic tapeworms (Caryophyllidea) from the Nearctic Region: taxonomic and evolutionary implications.
A comparative study of the scoleces of monozoic tapeworms (Cestoda: Caryophyllidea), parasites of catostomid and cyprinid fishes… 
2014
2014
The effect of UGT2B7*2 polymorphism on the pharmacokinetics of OROS® hydromorphone in Taiwanese subjects
This open‐label, single‐center, phase I study (NCT1487564) investigated the effect of uridine diphosphate… 
2011
2011
Clinical efficacy of OROS® hydromorphone in patients suffering from severe chronic pain: A Study undertaken in routine clinical practice
ZusammenfassungEINLEITUNG: Stark wirksame Opioide sind effektive Medikamente zur Behandlung von chronischen Schmerzen. Bei… 
2009
2009
OROS methylphenidate-induced skin eruptions.
2009
2009
Tolerability and effects of OROS® MPH (Concerta®) on functioning, severity of disease and quality of life in children and adolescents with ADHD: results from a prospective, non-interventional trial
Attention-deficit/hyperactivity disorder may have substantial impact on family life, peer interactions, and quality of life… 
2005
2005
12-month efficacy and safety of OROS® MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH
PurposeThe aim of this study was to evaluate long-term clinical treatment with OROS® methylphenidate (MPH) (Concerta®) in… 
2005
2005
Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS® MPH
AimThe aim of this study was to assess the impact of switching from immediate-release (IR) methylphenidate (MPH) to OROS® MPH… 
2004
2004
Effect of Antacid on the Pharmacokinetics of Extended-Release Formulations of Tolterodine and Oxybutynin
BackgroundIn general, extended-release (ER) formulations are designed to prolong the duration of efficacy and reduce the adverse… 
2001
2001
Methylphenidate (OROS® Formulation)
Abstract▲ Methylphenidate is a CNS stimulant that is thought to block the reuptake of dopamine and noradrenaline (norepinephrine… 
Review
1967
Review
1967
Further Indications of Clostridium botulinum in Latin American Waters.
ous types in fish and shellfish taken near the coasts of Venezuela and Columbia has been reported (B. J. Carroll, E. S. Garrett… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)